techMARK (TASX)

4,550.23
   
  • Change Today:
      34.68
  • 52 Week High: 4,740.82
  • 52 Week Low: 3,951.85

Latest ShareCast News

GSK's endometrial cancer drug receives FDA approval

By Iain Gilbert

Date: Wednesday 24 Apr 2024

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

techMARK Regulatory News

Transaction in Own Shares 26-Apr-2024 17:49 RNS
Notification of Major Holdings 26-Apr-2024 15:39 RNS
Form 8.3 - Spirent Communications plc 26-Apr-2024 15:20 RNS
Form 8.3 - Spirent Communications plc 26-Apr-2024 14:57 RNS
Form 8.3 - The Vanguard Group, Inc.: Spirent Com... 26-Apr-2024 14:54 EQS Group

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 4,550.23
Change Today 34.68
% Change 0.77 %
26-Apr-24 Close 4,550.23

Top Risers

Price Change
NCC 134.40p +5.2%
APTD 304.00p +4.1%
OXB 228.50p +3.9%
RSW 4,195.00p +3.2%
GNS 1,736.00p +1.9%
SN. 981.00p +1.7%
BA. 1,340.00p +1.5%
SGE 1,173.00p +1.1%
CCC 2,572.00p +0.9%
GSK 1,653.00p +0.8%

Top Fallers

Price Change
TRD 246.00p -5.4%
XAR 114.50p -4.6%
OXIG 2,180.00p -2.0%
BVC 18.93p -1.4%
XPP 1,084.00p -1.1%
RCDO 448.00p -0.4%
SPT 194.70p -0.2%
DIA 160.50p -0.0%

Top of Page